In the 6-OHDA rat model of PD, we were able to show that a dual-GLP-1/GIP receptor agonist can rescue dopaminergic neurons from the toxin and can increase dopamine levels in the striatum (Jalewa et al., 2017). This evidence concerns the gene GCG and Parkinson disease.